Impact of MDD Episode Duration and Recurrences

Charles Montano, MD; Carmen Kosicek, MSN, PMHNP-BC; and Gus Alva, MD, DFAPA, review the impact of the duration of MDD episodes and goals of managing episode recurrences.

Related Content:

Expert Perspectives on the Unmet Needs in the Management of Major Depressive DisorderDepression

FDA Review Sought for Lumateperone as Adjunctive Therapy for Major Depressive Disorder

Most US Adults Want Primary Care Physicians to Address Mental Health: Daily Dose

Three-Quarters of US Adults Want to Be Asked About Mental Health in Primary Care Visits: New Survey